Aurora Cannabis Inc. (ACB)
Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know
The mean of analysts' price targets for Aurora Cannabis (ACB) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Best Momentum Stocks to Buy for February 21st
ACB, BHRB and BJ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 21, 2024.
New Strong Buy Stocks for February 21st
BHRB, ACB, MWA, BJ and PRTH have been added to the Zacks Rank #1 (Strong Buy) List on February 21, 2024.
Best Value Stocks to Buy for February 21st
ACB, and PRTH made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 21, 2024.
All You Need to Know About Aurora Cannabis (ACB) Rating Upgrade to Strong Buy
Aurora Cannabis (ACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise
The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no federal reform that protects legal operators in any way. Yet states have independently voted to legalize cannabis. From this legal markets are created and legal companies can now produce a federally illegal product.
Aurora Cannabis Inc. (ACB) Q3 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB ) Q3 2025 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Kevin Niland - Director of Strategic Finance and Investor Relations Miguel Martin - Chief Executive Officer and Executive Chairman Simona King - Chief Financial Officer Conference Call Participants William Kirk - ROTH Capital Partners Frederico Gomes - ATB Capital Markets Derek Lessard - TD Cowen Matt Bottomley - Canaccord Genuity Douglas Miehm - RBC Capital Markets Operator Greetings and welcome to the Aurora Cannabis Inc. Third Quarter 2025 Results Conference Call. All participants will be in a listen-only mode and a question-and-answer session will follow the formal presentation.
Aurora Cannabis Inc. (ACB) Surpasses Q3 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.
3 Marijuana Stocks For Today Watchlist
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannabis politics surrounding reform and regulatory issues. Each party, Republicans and Democrats, walks a different path to passing comprehensive reform and looking at the sector as a whole.
Aurora Cannabis Inc. (ACB) Beats Q2 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.50 per share a year ago.
Aurora Cannabis Inc. (ACB) Q2 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB ) Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants Kevin Niland - Director, Strategic Finance and IR Miguel Martin - CEO Simona King - CFO Conference Call Participants Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Operator Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only mode and a question-and-answer session will follow the formal presentation.
ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
